Indo Us Bio-Tech Ltd

Indo Us Bio-Tech Ltd has announced the closure of its trading window for designated persons. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations 2015 and the company's internal code of conduct. The window will be shut from July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.

Indo Us Bio-Tech Ltd announced the resignation of M/s. Gautam N Associates, Chartered Accountants, as its Statutory Auditor, effective June 15, 2026. The resignation was attributed to administrative and operational restructuring, with the company seeking to economize operations and appoint a local auditor. Following this, the Board of Directors, based on the Audit Committee's recommendation, approved the appointment of M/s. Bhagat & Associates, Chartered Accountants, as the new Statutory Auditor. This appointment is effective from June 15, 2026, and is subject to the approval of shareholders at the next General Meeting.

Indo Us Bio-Tech Ltd announced changes in its statutory and internal auditors following a Board of Directors meeting on June 16, 2026. M/s. Gautam N Associates resigned as Statutory Auditor, replaced by M/s. Bhagat & Associates, subject to shareholder approval. M/s. Raj Shah & Co. resigned as Internal Auditor, with M/s. J. M. Raval & Co. appointed as their replacement for a five-year term.

Indo Us Bio-Tech Ltd announced changes in its audit team following a Board of Directors meeting on June 16, 2026. M/s. Gautam N Associates resigned as Statutory Auditor, and M/s. Bhagat & Associates have been appointed as their replacements, subject to shareholder approval. Additionally, M/s. Raj Shah & Co. resigned as Internal Auditor, with M/s. J. M. Raval & Co. appointed to the role for a five-year term starting FY2026-27. The changes are attributed to administrative and operational restructuring.

Indo Us Bio-Tech Ltd. announced its audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the standalone audited financial results in a meeting held on May 29, 2026. Revenue from operations stood at ₹11043.91 Lakhs for the year ended March 31, 2026, compared to ₹10363.34 Lakhs in the previous year. Net profit for the year was ₹1312.29 Lakhs. The results include an unmodified audit opinion from Gautam N Associates, Chartered Accountants.

Indo Us Bio-Tech Ltd has appointed Mrs. Hemanshi Darsh Soni (DIN: 11659183) as an Additional Director in the capacity of Non-Executive Independent Director. The appointment, effective from April 21, 2026, is subject to shareholder approval and is for a term of 5 years. Mrs. Soni is not related to any of the company's Directors or Key Managerial Personnel and does not hold directorship in any other listed entity. She is also not debarred from holding the office of Director by any SEBI order or other authority.

Indo Us Bio-Tech Ltd announced the revised resignation of Mrs. Nehaben Sachinbhai Patel (DIN: 09263180) from her position as Non-Executive and Independent Director. Her resignation, tendered via letters dated April 21, 2026, is effective from the same date. The company stated that the reason for her departure is "personal and unavoidable reasons." Mrs. Patel confirmed that there are no other material reasons for her resignation beyond those stated and that she does not hold any directorships in other listed entities.

Indo Us Bio-Tech Ltd. has announced the appointment of Mrs. Hemanshi Darsh Soni (DIN: 11659183) as an Additional Director, serving as a Non-Executive Independent Director. The Board of Directors approved her appointment on April 21, 2026, for a five-year term, effective from the same date. This appointment is contingent upon the approval of shareholders at the upcoming Annual General Meeting. The company confirmed that Mrs. Soni has no relation to any existing Directors or Key Managerial Personnel, ensuring her independence. The appointment adheres to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Companies Act, 2013.

Indo Us Bio-Tech Ltd announced the resignation of Mrs. Nehaben Sachinbhai Patel from her position as a Non-Executive and Independent Director. Her resignation, effective April 21, 2026, was tendered due to personal and unavoidable reasons. The company confirmed that no other material reasons were provided for her departure. This change in directorship is in compliance with SEBI Listing Regulations.

Indo Us Bio-Tech Ltd announced the resignation of Mrs. Nehaben Sachinbhai Patel (DIN: 09263180) from her position as a Non-Executive and Independent Director. Her resignation, citing personal and unavoidable reasons, was tendered via a letter dated April 21, 2026. The company's Board of Directors accepted her resignation at a meeting held on the same date, making it effective immediately. The company confirmed that no other material reasons for her departure were provided.